[如何改进维生素K拮抗剂抗凝治疗的监测。止血与血栓形成研究组的建议]
[How to improve the monitoring of anticoagulant therapy with antivitamins K. Recommendation of the Study Group on Hemostasis and Thrombosis].
出版信息
Rev Fr Gynecol Obstet. 1987 Feb;82(2):133-4.
PMID:3563287
Abstract
The study group on hemostasis and thrombosis calls the attention of the physicians to the fact that the Brussels community office has recommended the adoption of a new mode of expression of the results of the Quick time.
摘要
止血与血栓形成研究小组提请医生们注意这样一个事实，即布鲁塞尔社区办公室已建议采用一种新的表述Quick时间结果的方式。
相似文献
1
[How to improve the monitoring of anticoagulant therapy with antivitamins K. Recommendation of the Study Group on Hemostasis and Thrombosis].[如何改进维生素K拮抗剂抗凝治疗的监测。止血与血栓形成研究组的建议]
Rev Fr Gynecol Obstet. 1987 Feb;82(2):133-4.
2
3
[Anticoagulants. Antivitamins K: principles and rules of use, posology].[抗凝剂。维生素K拮抗剂：使用原则、规则及剂量]
Rev Prat. 1995 Apr 15;45(8):1014-7.
4
[Anticoagulant therapy with antivitamins K].[使用维生素K拮抗剂的抗凝治疗]
Klin Med (Mosk). 1984 Jan;62(1):18-24.
5
[Toward better monitoring of anticoagulant treatment with antivitamins K. Recommendations of the Hemostasis and Thrombosis Study Group].[关于使用维生素K拮抗剂改善抗凝治疗监测。止血与血栓研究组的建议]
Ann Cardiol Angeiol (Paris). 1986 Oct 30;35(8):499-500.
6
[Recommendations of the Hemostasis and Thrombosis Study Group. Toward better monitoring of anticoagulant treatment with antivitamins K].[止血与血栓形成研究小组的建议。旨在更好地监测抗维生素K类抗凝治疗]
Ann Med Interne (Paris). 1986;137(6):530-1.
7
[Heparins and antivitamins K].[肝素与维生素K拮抗剂]
Rev Paul Med. 1990 Jul-Aug;108(4):183-8.
8
[Hypersensitivity and resistance to antivitamins K].[对维生素K的超敏反应及耐药性]
Arch Mal Coeur Vaiss. 1995 Apr;88(4):487-95.
9
10
[Prevention of thromboembolic complications with adapted low-dose of antivitamins K after total hip prosthesis].
Rev Chir Orthop Reparatrice Appar Mot. 1993;79(7):577-85.
Zotero 插件